Nintedanib Inhibits Wnt3a-Induced Myofibroblast Activation by Suppressing the Src/β-Catenin Pathway
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nintedanib Inhibits Wnt3a-Induced Myofibroblast Activation by Suppressing the Src/β-Catenin Pathway
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-03-16
DOI
10.3389/fphar.2020.00310
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential of Nintedanib in Treatment of Progressive Fibrosing Interstitial Lung Diseases
- (2019) Lutz Wollin et al. EUROPEAN RESPIRATORY JOURNAL
- Src- and confinement-dependent FAK activation causes E-cadherin relaxation and β-catenin activity
- (2018) Charlène Gayrard et al. JOURNAL OF CELL BIOLOGY
- Mechanisms of Wnt signaling and control
- (2018) Stephanie Grainger et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Protective Effects of Nintedanib against Polyhexamethylene Guanidine Phosphate-Induced Lung Fibrosis in Mice
- (2018) Hyeon-Young Kim et al. MOLECULES
- Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway
- (2017) Li-Fu Li et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Idiopathic pulmonary fibrosis
- (2017) Fernando J. Martinez et al. Nature Reviews Disease Primers
- Novel Mechanisms for the Antifibrotic Action of Nintedanib
- (2016) Sunad Rangarajan et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
- (2016) Martin Kolb et al. THORAX
- Novel Bioluminescent Activatable Reporter for Src Tyrosine Kinase Activity in Living Mice
- (2016) Author Weibing Leng et al. Theranostics
- Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
- (2015) Jingang Huang et al. ANNALS OF THE RHEUMATIC DISEASES
- The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
- (2015) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Experimental design and analysis and their reporting: new guidance for publication in BJP
- (2015) Michael J Curtis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP
- (2015) John C McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Nintedanib: From Discovery to the Clinic
- (2015) Gerald J. Roth et al. JOURNAL OF MEDICINAL CHEMISTRY
- The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
- (2015) Christopher Southan et al. NUCLEIC ACIDS RESEARCH
- Nintedanib modulates surfactant protein-D expression in A549 human lung epithelial cells via the c-Jun N-terminal kinase-activator protein-1 pathway
- (2015) Koichiro Kamio et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Fibrosis: ultimate and proximate causes
- (2014) Victor J. Thannickal et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nintedanib: A Novel Therapeutic Approach for Idiopathic Pulmonary Fibrosis
- (2014) I. A. Dimitroulis Respiratory Care
- Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11
- (2014) Ganesh Raghu et al. Lancet Respiratory Medicine
- Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activation
- (2013) Y-L Chen et al. Cell Death & Disease
- Thiazolyl N-benzyl-substituted acetamide derivatives: Synthesis, Src kinase inhibitory and anticancer activities
- (2011) Asal Fallah-Tafti et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Axin Pathway Activity Regulatesin VivopY654-β-catenin Accumulation and Pulmonary Fibrosis
- (2011) Arnau Ulsamer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development
- (2011) Y. Geng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blockade of the Wnt/β-Catenin Pathway Attenuates Bleomycin-Induced Pulmonary Fibrosis
- (2011) Tae Hyung Kim et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis
- (2010) Corrine R. Kliment et al. FREE RADICAL BIOLOGY AND MEDICINE
- WNT1-inducible signaling protein–1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis
- (2009) Melanie Königshoff et al. JOURNAL OF CLINICAL INVESTIGATION
- BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
- (2008) F. Hilberg et al. CANCER RESEARCH
- Epithelial cell α3β1 integrin links β-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis
- (2008) Kevin K. Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
- Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis
- (2008) Melanie Königshoff et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now